Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXC9
|
ENSG00000180806.4 | homeobox C9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_54394241_54394522 | HOXC9 | 478 | 0.391807 | -0.20 | 6.0e-01 | Click! |
chr12_54393897_54394133 | HOXC9 | 112 | 0.617050 | -0.18 | 6.4e-01 | Click! |
chr12_54396371_54396522 | HOXC9 | 2543 | 0.088604 | -0.13 | 7.4e-01 | Click! |
chr12_54388856_54389199 | HOXC9 | 266 | 0.421568 | -0.07 | 8.6e-01 | Click! |
chr12_54394726_54394877 | HOXC9 | 898 | 0.231338 | -0.03 | 9.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_12598337_12598791 | 1.27 |
SPIRE1 |
spire-type actin nucleation factor 1 |
54520 |
0.09 |
chr2_64881941_64882849 | 1.09 |
SERTAD2 |
SERTA domain containing 2 |
1348 |
0.52 |
chr1_183776609_183776992 | 1.02 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
2510 |
0.36 |
chr1_31870163_31870721 | 0.96 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr8_78478320_78478688 | 0.93 |
ENSG00000222334 |
. |
279452 |
0.02 |
chr12_29895057_29895338 | 0.92 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
41534 |
0.21 |
chr5_40401420_40402168 | 0.91 |
ENSG00000265615 |
. |
81374 |
0.11 |
chr2_193011022_193011173 | 0.91 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
48153 |
0.19 |
chr1_67397953_67399117 | 0.90 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
2609 |
0.29 |
chr12_89339824_89340184 | 0.78 |
ENSG00000238302 |
. |
336058 |
0.01 |
chr3_81789805_81790284 | 0.77 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
2736 |
0.44 |
chr17_42872109_42872587 | 0.77 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
9986 |
0.14 |
chr1_167517405_167517629 | 0.74 |
CREG1 |
cellular repressor of E1A-stimulated genes 1 |
5487 |
0.22 |
chr3_172394693_172395213 | 0.74 |
ENSG00000264711 |
. |
5524 |
0.18 |
chr4_40623166_40623743 | 0.74 |
RBM47 |
RNA binding motif protein 47 |
8427 |
0.27 |
chr5_115790516_115790946 | 0.73 |
CTB-118N6.3 |
|
5305 |
0.26 |
chr9_90215657_90216062 | 0.72 |
DAPK1-IT1 |
DAPK1 intronic transcript 1 (non-protein coding) |
47490 |
0.16 |
chr12_64846967_64847658 | 0.71 |
TBK1 |
TANK-binding kinase 1 |
1057 |
0.53 |
chr6_88407042_88408017 | 0.70 |
AKIRIN2 |
akirin 2 |
4398 |
0.23 |
chr2_40612222_40612511 | 0.69 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
45054 |
0.2 |
chr21_40683413_40684326 | 0.69 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
1627 |
0.24 |
chr15_49336349_49337349 | 0.69 |
SECISBP2L |
SECIS binding protein 2-like |
1781 |
0.28 |
chr16_53809610_53810340 | 0.68 |
FTO |
fat mass and obesity associated |
71881 |
0.11 |
chr1_200333826_200333977 | 0.67 |
ZNF281 |
zinc finger protein 281 |
45219 |
0.19 |
chr2_161232105_161232912 | 0.67 |
ENSG00000252465 |
. |
20971 |
0.19 |
chr6_114290051_114291212 | 0.67 |
RP3-399L15.3 |
|
234 |
0.87 |
chr3_189791102_189791307 | 0.66 |
ENSG00000265045 |
. |
40519 |
0.14 |
chr22_19073574_19073725 | 0.66 |
AC004471.9 |
|
35393 |
0.09 |
chr10_99995580_99995731 | 0.64 |
RP11-34A14.3 |
|
16125 |
0.21 |
chr5_141320945_141321328 | 0.62 |
KIAA0141 |
KIAA0141 |
8171 |
0.13 |
chr4_54425031_54425364 | 0.61 |
LNX1 |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
813 |
0.67 |
chr16_69255951_69256102 | 0.61 |
RP11-70O5.2 |
|
18426 |
0.12 |
chr9_116639997_116640288 | 0.60 |
ZNF618 |
zinc finger protein 618 |
1512 |
0.52 |
chr16_4103086_4103844 | 0.59 |
RP11-462G12.4 |
|
21452 |
0.2 |
chr1_172255657_172255977 | 0.59 |
ENSG00000252354 |
. |
61466 |
0.11 |
chr10_17714984_17715727 | 0.59 |
ENSG00000251959 |
. |
5832 |
0.17 |
chr2_28578659_28578961 | 0.59 |
FOSL2 |
FOS-like antigen 2 |
36859 |
0.13 |
chr5_39411390_39411705 | 0.59 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
13423 |
0.26 |
chr1_208115334_208115485 | 0.59 |
CD34 |
CD34 molecule |
30662 |
0.24 |
chr9_80747244_80748140 | 0.58 |
ENSG00000222452 |
. |
32689 |
0.22 |
chr13_42274733_42275224 | 0.58 |
ENSG00000241406 |
. |
106835 |
0.07 |
chr6_125335196_125335438 | 0.57 |
RNF217 |
ring finger protein 217 |
30803 |
0.21 |
chr11_36387843_36388116 | 0.57 |
PRR5L |
proline rich 5 like |
4321 |
0.24 |
chr3_149290836_149290987 | 0.56 |
WWTR1 |
WW domain containing transcription regulator 1 |
3128 |
0.27 |
chr3_188994486_188994762 | 0.56 |
TPRG1-AS2 |
TPRG1 antisense RNA 2 |
36241 |
0.21 |
chr3_15834561_15835314 | 0.56 |
ANKRD28 |
ankyrin repeat domain 28 |
3091 |
0.28 |
chr7_116211652_116211947 | 0.56 |
AC006159.4 |
|
511 |
0.78 |
chr1_27626590_27626805 | 0.55 |
TMEM222 |
transmembrane protein 222 |
21954 |
0.11 |
chr8_130698164_130698381 | 0.55 |
GSDMC |
gasdermin C |
100862 |
0.07 |
chr7_41909334_41909592 | 0.55 |
AC005027.3 |
|
164530 |
0.04 |
chr4_57909352_57909761 | 0.55 |
ENSG00000251703 |
. |
40698 |
0.11 |
chr13_21632728_21633071 | 0.55 |
LATS2 |
large tumor suppressor kinase 2 |
1530 |
0.35 |
chr8_8168819_8168970 | 0.55 |
ALG1L13P |
asparagine-linked glycosylation 1-like 13, pseudogene |
69961 |
0.09 |
chr2_153277819_153278036 | 0.55 |
FMNL2 |
formin-like 2 |
86176 |
0.1 |
chr8_57806614_57806867 | 0.55 |
ENSG00000206975 |
. |
22903 |
0.26 |
chr3_187978157_187978521 | 0.55 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
20687 |
0.25 |
chr7_111626824_111627073 | 0.54 |
DOCK4 |
dedicator of cytokinesis 4 |
17238 |
0.24 |
chr12_65700883_65701407 | 0.54 |
MSRB3 |
methionine sulfoxide reductase B3 |
19510 |
0.22 |
chr15_82422353_82422648 | 0.54 |
RP11-597K23.2 |
Uncharacterized protein |
41468 |
0.14 |
chr2_178283039_178283431 | 0.54 |
AGPS |
alkylglycerone phosphate synthase |
25739 |
0.14 |
chr11_75657287_75657506 | 0.54 |
ENSG00000223013 |
. |
11416 |
0.16 |
chr2_26232303_26232586 | 0.53 |
AC013449.1 |
Uncharacterized protein |
19037 |
0.15 |
chr2_225010185_225010480 | 0.53 |
ENSG00000211987 |
. |
93941 |
0.08 |
chr19_6103075_6103226 | 0.53 |
CTB-66B24.1 |
|
6183 |
0.15 |
chr10_30734331_30734677 | 0.53 |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
6753 |
0.24 |
chr2_197264610_197264832 | 0.53 |
HECW2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
37775 |
0.2 |
chr5_59397789_59398062 | 0.52 |
CTD-2254N19.1 |
|
71212 |
0.12 |
chr9_75764547_75765336 | 0.52 |
ANXA1 |
annexin A1 |
1732 |
0.5 |
chr9_127030175_127030580 | 0.52 |
RP11-121A14.3 |
|
5222 |
0.19 |
chr13_51163491_51163724 | 0.52 |
DLEU7-AS1 |
DLEU7 antisense RNA 1 |
218385 |
0.02 |
chr10_17827029_17827503 | 0.51 |
MRC1L1 |
cDNA FLJ56855, highly similar to Macrophage mannose receptor 1 |
24096 |
0.17 |
chr1_161973787_161974282 | 0.51 |
OLFML2B |
olfactomedin-like 2B |
19012 |
0.22 |
chr1_68640359_68640547 | 0.51 |
ENSG00000221203 |
. |
8840 |
0.22 |
chr11_15128125_15128276 | 0.51 |
INSC |
inscuteable homolog (Drosophila) |
5770 |
0.28 |
chr16_81638343_81638641 | 0.51 |
CMIP |
c-Maf inducing protein |
40471 |
0.2 |
chr2_226983987_226984250 | 0.51 |
ENSG00000263363 |
. |
539391 |
0.0 |
chr1_114520883_114521106 | 0.50 |
OLFML3 |
olfactomedin-like 3 |
1069 |
0.49 |
chr3_188139152_188139752 | 0.50 |
LPP-AS1 |
LPP antisense RNA 1 |
147002 |
0.04 |
chr2_33467839_33468340 | 0.50 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
640 |
0.79 |
chr3_182992678_182993398 | 0.50 |
B3GNT5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
9906 |
0.2 |
chr11_34449252_34449782 | 0.50 |
CAT |
catalase |
10955 |
0.23 |
chr22_18539461_18539695 | 0.50 |
XXbac-B476C20.9 |
|
20985 |
0.13 |
chr3_142719040_142719191 | 0.50 |
U2SURP |
U2 snRNP-associated SURP domain containing |
1251 |
0.46 |
chr15_77713627_77714545 | 0.50 |
HMG20A |
high mobility group 20A |
733 |
0.64 |
chr4_48256106_48256549 | 0.50 |
TEC |
tec protein tyrosine kinase |
15554 |
0.23 |
chr16_27590290_27590441 | 0.49 |
KIAA0556 |
KIAA0556 |
5137 |
0.22 |
chr20_5705538_5705977 | 0.49 |
C20orf196 |
chromosome 20 open reading frame 196 |
25282 |
0.23 |
chr6_140892392_140892543 | 0.49 |
ENSG00000221336 |
. |
89383 |
0.1 |
chr17_60074998_60075962 | 0.49 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr18_53177775_53178126 | 0.49 |
TCF4 |
transcription factor 4 |
50 |
0.98 |
chr21_40361446_40361610 | 0.49 |
ENSG00000272015 |
. |
94819 |
0.08 |
chr18_46355342_46355813 | 0.49 |
RP11-484L8.1 |
|
5564 |
0.29 |
chr3_149088815_149089173 | 0.49 |
TM4SF1 |
transmembrane 4 L six family member 1 |
4505 |
0.2 |
chr8_123122166_123122317 | 0.48 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
468565 |
0.01 |
chr5_14439490_14439641 | 0.48 |
TRIO |
trio Rho guanine nucleotide exchange factor |
48992 |
0.18 |
chr9_81313324_81313640 | 0.48 |
PSAT1 |
phosphoserine aminotransferase 1 |
401423 |
0.01 |
chr15_81631153_81631419 | 0.48 |
RP11-761I4.3 |
|
2703 |
0.27 |
chr5_14400569_14400746 | 0.48 |
TRIO |
trio Rho guanine nucleotide exchange factor |
87900 |
0.1 |
chr5_80922589_80922740 | 0.48 |
SSBP2 |
single-stranded DNA binding protein 2 |
113128 |
0.07 |
chr22_37908842_37909144 | 0.48 |
CARD10 |
caspase recruitment domain family, member 10 |
745 |
0.57 |
chr13_73354563_73355562 | 0.48 |
DIS3 |
DIS3 mitotic control homolog (S. cerevisiae) |
1001 |
0.39 |
chr13_40684091_40684242 | 0.48 |
ENSG00000207458 |
. |
116798 |
0.07 |
chr16_53246810_53247380 | 0.48 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
4732 |
0.24 |
chr13_33853268_33853419 | 0.48 |
ENSG00000236581 |
. |
1653 |
0.41 |
chr1_178244577_178244818 | 0.48 |
RASAL2 |
RAS protein activator like 2 |
65909 |
0.14 |
chr1_61607422_61607671 | 0.48 |
RP4-802A10.1 |
|
17141 |
0.23 |
chr18_3454886_3455393 | 0.48 |
TGIF1 |
TGFB-induced factor homeobox 1 |
11 |
0.98 |
chr18_52995287_52995506 | 0.48 |
TCF4 |
transcription factor 4 |
5871 |
0.31 |
chr12_26303323_26303715 | 0.47 |
SSPN |
sarcospan |
15619 |
0.18 |
chr3_136505593_136506225 | 0.47 |
SLC35G2 |
solute carrier family 35, member G2 |
31952 |
0.12 |
chr16_85084815_85085194 | 0.47 |
KIAA0513 |
KIAA0513 |
11814 |
0.21 |
chr12_6198255_6198797 | 0.47 |
ENSG00000240533 |
. |
6610 |
0.23 |
chr2_159947065_159947542 | 0.47 |
ENSG00000202029 |
. |
63649 |
0.13 |
chr11_103396303_103396486 | 0.47 |
DYNC2H1 |
dynein, cytoplasmic 2, heavy chain 1 |
167423 |
0.04 |
chr17_53804938_53805089 | 0.47 |
TMEM100 |
transmembrane protein 100 |
4469 |
0.29 |
chr6_86155572_86155723 | 0.47 |
NT5E |
5'-nucleotidase, ecto (CD73) |
4162 |
0.33 |
chr7_82224652_82224988 | 0.47 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
151706 |
0.05 |
chr14_23775130_23775401 | 0.47 |
BCL2L2 |
BCL2-like 2 |
706 |
0.31 |
chr11_112027840_112028079 | 0.47 |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
6838 |
0.11 |
chr10_62186857_62187008 | 0.46 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
37444 |
0.23 |
chr22_32267281_32267544 | 0.46 |
DEPDC5 |
DEP domain containing 5 |
18510 |
0.16 |
chr4_160113629_160113918 | 0.46 |
ENSG00000264105 |
. |
63727 |
0.11 |
chr11_116784063_116784557 | 0.46 |
SIK3-IT1 |
SIK3 intronic transcript 1 (non-protein coding) |
22873 |
0.14 |
chr9_124033827_124034080 | 0.46 |
GSN |
gelsolin |
3573 |
0.18 |
chr6_22026198_22026944 | 0.46 |
ENSG00000222515 |
. |
59202 |
0.17 |
chr12_91290582_91290865 | 0.46 |
CCER1 |
coiled-coil glutamate-rich protein 1 |
58230 |
0.15 |
chr8_69646501_69646652 | 0.46 |
ENSG00000239184 |
. |
38698 |
0.22 |
chr9_81321983_81322311 | 0.46 |
PSAT1 |
phosphoserine aminotransferase 1 |
410088 |
0.01 |
chr6_133033571_133033918 | 0.46 |
VNN1 |
vanin 1 |
1444 |
0.34 |
chr8_123147466_123147695 | 0.46 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
493904 |
0.0 |
chr2_40328493_40328783 | 0.45 |
SLC8A1-AS1 |
SLC8A1 antisense RNA 1 |
3411 |
0.39 |
chr1_97610616_97610767 | 0.45 |
DPYD-AS1 |
DPYD antisense RNA 1 |
49212 |
0.19 |
chr15_59462353_59462672 | 0.45 |
ENSG00000253030 |
. |
949 |
0.42 |
chr3_156506429_156506580 | 0.45 |
LEKR1 |
leucine, glutamate and lysine rich 1 |
37585 |
0.2 |
chr11_9587986_9588266 | 0.45 |
WEE1 |
WEE1 G2 checkpoint kinase |
7102 |
0.16 |
chr3_172036360_172036556 | 0.45 |
AC092964.1 |
Uncharacterized protein |
2240 |
0.34 |
chr12_10344371_10344522 | 0.45 |
TMEM52B |
transmembrane protein 52B |
12333 |
0.12 |
chr16_19129843_19130268 | 0.45 |
RP11-626G11.3 |
|
2896 |
0.21 |
chr16_69510453_69510859 | 0.45 |
CYB5B |
cytochrome b5 type B (outer mitochondrial membrane) |
51970 |
0.1 |
chr2_208121057_208121376 | 0.45 |
AC007879.5 |
|
2240 |
0.34 |
chr20_58563521_58563805 | 0.45 |
CDH26 |
cadherin 26 |
498 |
0.81 |
chr22_24798801_24798960 | 0.45 |
ADORA2A |
adenosine A2a receptor |
20685 |
0.18 |
chr7_75164072_75164427 | 0.45 |
PMS2P3 |
postmeiotic segregation increased 2 pseudogene 3 |
7110 |
0.15 |
chr7_93690848_93690999 | 0.45 |
BET1 |
Bet1 golgi vesicular membrane trafficking protein |
57229 |
0.14 |
chr17_35974821_35975108 | 0.45 |
RP11-697E22.1 |
|
5177 |
0.17 |
chr9_79075654_79076239 | 0.45 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1800 |
0.46 |
chr17_57846998_57847149 | 0.45 |
VMP1 |
vacuole membrane protein 1 |
4042 |
0.2 |
chr10_126846033_126846605 | 0.45 |
CTBP2 |
C-terminal binding protein 2 |
966 |
0.69 |
chr5_77798034_77798185 | 0.45 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
46865 |
0.18 |
chr2_164207451_164207602 | 0.44 |
ENSG00000200902 |
. |
62021 |
0.16 |
chr7_101584838_101585234 | 0.44 |
CTB-181H17.1 |
|
18360 |
0.23 |
chr8_96714411_96714562 | 0.44 |
ENSG00000223297 |
. |
23343 |
0.26 |
chr17_71303101_71303370 | 0.44 |
CDC42EP4 |
CDC42 effector protein (Rho GTPase binding) 4 |
4312 |
0.22 |
chr5_52655252_52655542 | 0.44 |
FST |
follistatin |
120842 |
0.06 |
chr4_79705695_79705981 | 0.44 |
BMP2K |
BMP2 inducible kinase |
8306 |
0.19 |
chr10_75726148_75726415 | 0.44 |
VCL |
vinculin |
31591 |
0.12 |
chr7_116712734_116712923 | 0.44 |
ST7-AS2 |
ST7 antisense RNA 2 |
1950 |
0.33 |
chr12_13247017_13247257 | 0.44 |
GSG1 |
germ cell associated 1 |
1445 |
0.43 |
chr6_52425530_52425681 | 0.44 |
TRAM2 |
translocation associated membrane protein 2 |
16108 |
0.24 |
chr8_25032357_25032508 | 0.44 |
ENSG00000241811 |
. |
6803 |
0.25 |
chr22_37908037_37908429 | 0.44 |
CARD10 |
caspase recruitment domain family, member 10 |
15 |
0.97 |
chr5_127294983_127295134 | 0.44 |
SLC12A2 |
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
124400 |
0.06 |
chr14_103480838_103481545 | 0.44 |
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
42608 |
0.12 |
chr4_48332474_48332625 | 0.44 |
SLAIN2 |
SLAIN motif family, member 2 |
10790 |
0.24 |
chr1_59231029_59231230 | 0.43 |
ENSG00000264081 |
. |
522 |
0.8 |
chr3_32185972_32186147 | 0.43 |
ENSG00000238646 |
. |
28089 |
0.16 |
chr15_68406407_68406736 | 0.43 |
PIAS1 |
protein inhibitor of activated STAT, 1 |
59657 |
0.12 |
chr1_26187643_26188072 | 0.43 |
RP1-125I3.2 |
|
1753 |
0.17 |
chr18_9731207_9731358 | 0.43 |
RAB31 |
RAB31, member RAS oncogene family |
23120 |
0.2 |
chr11_33712841_33713004 | 0.43 |
RP4-541C22.5 |
|
5325 |
0.18 |
chr1_64638258_64638590 | 0.43 |
RP11-24J23.2 |
|
1444 |
0.46 |
chr5_81702467_81702618 | 0.43 |
ATP6AP1L |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
101376 |
0.08 |
chr4_139327101_139327252 | 0.43 |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
163673 |
0.04 |
chr15_86016825_86017700 | 0.43 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
70009 |
0.09 |
chr4_48727990_48728340 | 0.43 |
FRYL |
FRY-like |
44977 |
0.16 |
chr4_169526190_169526341 | 0.43 |
PALLD |
palladin, cytoskeletal associated protein |
26501 |
0.19 |
chr5_81460698_81461288 | 0.43 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr11_78509149_78509300 | 0.43 |
TENM4 |
teneurin transmembrane protein 4 |
7232 |
0.27 |
chr2_163101483_163101634 | 0.43 |
FAP |
fibroblast activation protein, alpha |
1513 |
0.46 |
chr4_170146180_170146331 | 0.42 |
RP11-327O17.2 |
|
23310 |
0.22 |
chr20_52354290_52354570 | 0.42 |
ENSG00000238468 |
. |
69133 |
0.12 |
chr7_47541782_47542068 | 0.42 |
TNS3 |
tensin 3 |
21042 |
0.28 |
chr6_56820926_56821126 | 0.42 |
BEND6 |
BEN domain containing 6 |
856 |
0.52 |
chr1_206846612_206846999 | 0.42 |
ENSG00000252853 |
. |
8503 |
0.14 |
chr14_53268642_53268793 | 0.42 |
GNPNAT1 |
glucosamine-phosphate N-acetyltransferase 1 |
10331 |
0.16 |
chr6_114018570_114018876 | 0.42 |
ENSG00000221559 |
. |
7312 |
0.27 |
chr7_41465174_41465470 | 0.42 |
INHBA-AS1 |
INHBA antisense RNA 1 |
268192 |
0.02 |
chr8_8483741_8483892 | 0.42 |
ENSG00000264445 |
. |
7158 |
0.25 |
chr20_10521233_10521444 | 0.42 |
SLX4IP |
SLX4 interacting protein |
105387 |
0.06 |
chr15_45881879_45882313 | 0.42 |
BLOC1S6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
2073 |
0.2 |
chr1_109912007_109912390 | 0.42 |
SORT1 |
sortilin 1 |
23781 |
0.14 |
chr1_39624769_39624920 | 0.42 |
ENSG00000222378 |
. |
4876 |
0.2 |
chr7_101596544_101596695 | 0.42 |
CTB-181H17.1 |
|
6777 |
0.27 |
chr15_71006405_71006665 | 0.42 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
10921 |
0.26 |
chr6_134744399_134744550 | 0.42 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
105224 |
0.07 |
chr1_87239226_87239594 | 0.42 |
SH3GLB1 |
SH3-domain GRB2-like endophilin B1 |
68832 |
0.09 |
chr3_194041385_194041965 | 0.41 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
30372 |
0.17 |
chr2_86644875_86645090 | 0.41 |
KDM3A |
lysine (K)-specific demethylase 3A |
22788 |
0.17 |
chr10_126835454_126835747 | 0.41 |
CTBP2 |
C-terminal binding protein 2 |
11685 |
0.28 |
chr1_109938801_109939938 | 0.41 |
SORT1 |
sortilin 1 |
1204 |
0.42 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.8 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 1.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.5 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.8 | GO:0071221 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.2 | 0.6 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.8 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.5 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.6 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.2 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.6 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.2 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.6 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.7 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 1.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.1 | GO:0051133 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.1 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.6 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.4 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.3 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.1 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.0 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.2 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.2 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.2 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 1.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.1 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.6 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 2.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 4.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 1.0 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.3 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.3 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.7 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.8 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.5 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.6 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.7 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 4.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 2.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 1.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |